<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32467165</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>117</Volume><Issue>24</Issue><PubDate><Year>2020</Year><Month>Jun</Month><Day>16</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Inhibitory antibodies identify unique sites of therapeutic vulnerability in rhinovirus and other enteroviruses.</ArticleTitle><Pagination><StartPage>13499</StartPage><EndPage>13508</EndPage><MedlinePgn>13499-13508</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1918844117</ELocationID><Abstract><AbstractText>The existence of multiple serotypes renders vaccine development challenging for most viruses in the <i>Enterovirus</i> genus. An alternative and potentially more viable strategy for control of these viruses is to develop broad-spectrum antivirals by targeting highly conserved proteins that are indispensable for the virus life cycle, such as the 3C protease. Previously, two single-chain antibody fragments, YDF and GGVV, were reported to effectively inhibit human rhinovirus 14 proliferation. Here, we found that both single-chain antibody fragments target sites on the 3C protease that are distinct from its known drug site (peptidase active site) and possess different mechanisms of inhibition. YDF does not block the active site but instead noncompetitively inhibits 3C peptidase activity through an allosteric effect that is rarely seen for antibody protease inhibitors. Meanwhile, GGVV antagonizes the less-explored regulatory function of 3C in genome replication. The interaction between 3C and the viral genome 5' noncoding region has been reported to be important for enterovirus genome replication. Here, the interface between human rhinovirus 14 3C and its 5' noncoding region was probed by hydrogen-deuterium exchange coupled mass spectrometry and found to partially overlap with the interface between GGVV and 3C. Consistently, prebinding of GGVV completely abolishes interaction between human rhinovirus 14 3C and its 5' noncoding region. The epitopes of YDF and GGVV, therefore, represent two additional sites of therapeutic vulnerability in rhinovirus. Importantly, the GGVV epitope appears to be conserved across many enteroviruses, suggesting that it is a promising target for pan-enterovirus inhibitor screening and design.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 the Author(s). Published by PNAS.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Bing</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, 201210 Shanghai, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lan</LastName><ForeName>Keke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, 201210 Shanghai, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Life Science and Technology, ShanghaiTech University, 201210 Shanghai, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Jia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Chemistry, The Scripps Research Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lerner</LastName><ForeName>Richard A</ForeName><Initials>RA</Initials><Identifier Source="ORCID">0000-0003-4399-874X</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, The Scripps Research Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Ian A</ForeName><Initials>IA</Initials><Identifier Source="ORCID">0000-0002-6469-2419</Identifier><AffiliationInfo><Affiliation>Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, 201210 Shanghai, People's Republic of China; wilson@scripps.edu yangbei@shanghaitech.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Bei</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-5389-3859</Identifier><AffiliationInfo><Affiliation>Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, 201210 Shanghai, People's Republic of China; wilson@scripps.edu yangbei@shanghaitech.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020121">5' Untranslated Regions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057127">Single-Chain Antibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.28</RegistryNumber><NameOfSubstance UI="D000086042">3C Viral Proteases</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000623735">Rhinovirus B</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086042" MajorTopicYN="N">3C Viral Proteases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020121" MajorTopicYN="N">5' Untranslated Regions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000494" MajorTopicYN="N">Allosteric Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000495" MajorTopicYN="N">Allosteric Site</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016679" MajorTopicYN="N">Genome, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057127" MajorTopicYN="N">Single-Chain Antibodies</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HDX-MS</Keyword><Keyword MajorTopicYN="N">X-ray crystallography</Keyword><Keyword MajorTopicYN="N">allosteric inhibitor</Keyword><Keyword MajorTopicYN="N">genome replication regulation</Keyword><Keyword MajorTopicYN="N">pan-enterovirus antiviral target</Keyword></KeywordList><CoiStatement>The authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>5</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32467165</ArticleId><ArticleId IdType="pmc">PMC7306783</ArticleId><ArticleId IdType="doi">10.1073/pnas.1918844117</ArticleId><ArticleId IdType="pii">1918844117</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van der Linden L., Wolthers K. C., van Kuppeveld F. J., Replication and inhibitors of enteroviruses and Parechoviruses. Viruses 7, 4529&#x2013;4562 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4576193</ArticleId><ArticleId IdType="pubmed">26266417</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmenberg A. C., Gern J. E., Classification and evolution of human rhinoviruses. Methods Mol. Biol. 1221, 1&#x2013;10 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4441521</ArticleId><ArticleId IdType="pubmed">25261302</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapparel C., Siegrist F., Petty T. J., Kaiser L., Picornavirus and enterovirus diversity with associated human diseases. Infect. Genet. Evol. 14, 282&#x2013;293 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23201849</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs S. E., Lamson D. M., St George K., Walsh T. J., Human rhinoviruses. Clin. Microbiol. Rev. 26, 135&#x2013;162 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3553670</ArticleId><ArticleId IdType="pubmed">23297263</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner R. B., Rhinovirus: More than just a common cold virus. J. Infect. Dis. 195, 765&#x2013;766 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17299703</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamieson K. C., Warner S. M., Leigh R., Proud D., Rhinovirus in the pathogenesis and clinical course of asthma. Chest 148, 1508&#x2013;1516 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26270739</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L., Lyoo H., van der Schaar H. M., Strating J. R., van Kuppeveld F. J., Direct-acting antivirals and host-targeting strategies to combat enterovirus infections. Curr. Opin. Virol. 24, 1&#x2013;8 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172203</ArticleId><ArticleId IdType="pubmed">28411509</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J., Thibaut H. J., Strating J. R. P. M., van Kuppeveld F. J. M., The life cycle of non-polio enteroviruses and how to target it. Nat. Rev. Microbiol. 16, 368&#x2013;381 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen L. M., Walker E. J., Jans D. A., Ghildyal R., Proteases of human rhinovirus: Role in infection. Methods Mol. Biol. 1221, 129&#x2013;141 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25261311</ArticleId></ArticleIdList></Reference><Reference><Citation>Laitinen O. H. et al. ., Enteroviral proteases: Structure, host interactions and pathogenicity. Rev. Med. Virol. 26, 251&#x2013;267 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7169145</ArticleId><ArticleId IdType="pubmed">27145174</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Xiao X., Wang J., Innate immunity evasion by enteroviruses: Insights into virus-host interaction. Viruses 8, E22 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4728582</ArticleId><ArticleId IdType="pubmed">26784219</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanway G., Structure, function and evolution of picornaviruses. J. Gen. Virol. 71, 2483&#x2013;2501 (1990).</Citation><ArticleIdList><ArticleId IdType="pubmed">2254747</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews D. A. et al. ., Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein. Cell 77, 761&#x2013;771 (1994).</Citation><ArticleIdList><ArticleId IdType="pubmed">7515772</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjorndahl T. C., Andrew L. C., Semenchenko V., Wishart D. S., NMR solution structures of the apo and peptide-inhibited human rhinovirus 3C protease (Serotype 14): Structural and dynamic comparison. Biochemistry 46, 12945&#x2013;12958 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17944485</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews D. A. et al. ., Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. Proc. Natl. Acad. Sci. U.S.A. 96, 11000&#x2013;11007 (1999).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC34232</ArticleId><ArticleId IdType="pubmed">10500114</ArticleId></ArticleIdList></Reference><Reference><Citation>Dragovich P. S. et al. ., Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics. J. Med. Chem. 46, 4572&#x2013;4585 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">14521419</ArticleId></ArticleIdList></Reference><Reference><Citation>Patick A. K. et al. ., In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease. Antimicrob. Agents Chemother. 43, 2444&#x2013;2450 (1999).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC89498</ArticleId><ArticleId IdType="pubmed">10508022</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden F. G. et al. ., Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers. Antimicrob. Agents Chemother. 47, 3907&#x2013;3916 (2003).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC296196</ArticleId><ArticleId IdType="pubmed">14638501</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauske P., Ottmann C., Meltzer M., Ehrmann M., Kaiser M., Allosteric regulation of proteases. ChemBioChem 9, 2920&#x2013;2928 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">19021141</ArticleId></ArticleIdList></Reference><Reference><Citation>Andino R., Rieckhof G. E., Baltimore D., A functional ribonucleoprotein complex forms around the 5&#x2032; end of poliovirus RNA. Cell 63, 369&#x2013;380 (1990).</Citation><ArticleIdList><ArticleId IdType="pubmed">2170027</ArticleId></ArticleIdList></Reference><Reference><Citation>Leong L. E., Walker P. A., Porter A. G., Human rhinovirus-14 protease 3C (3Cpro) binds specifically to the 5&#x2032;-noncoding region of the viral RNA. Evidence that 3Cpro has different domains for the RNA binding and proteolytic activities. J. Biol. Chem. 268, 25735&#x2013;25739 (1993).</Citation><ArticleIdList><ArticleId IdType="pubmed">8245010</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang W., Harris K. S., Alexander L., Wimmer E., Interaction between the 5&#x2032;-terminal cloverleaf and 3AB/3CDpro of poliovirus is essential for RNA replication. J. Virol. 69, 3658&#x2013;3667 (1995).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189081</ArticleId><ArticleId IdType="pubmed">7745714</ArticleId></ArticleIdList></Reference><Reference><Citation>Zell R., Sidigi K., Bucci E., Stelzner A., G&#xf6;rlach M., Determinants of the recognition of enteroviral cloverleaf RNA by coxsackievirus B3 proteinase 3C. RNA 8, 188&#x2013;201 (2002).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1370242</ArticleId><ArticleId IdType="pubmed">11911365</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih S. R. et al. ., Mutations at KFRDI and VGK domains of enterovirus 71 3C protease affect its RNA binding and proteolytic activities. J. Biomed. Sci. 11, 239&#x2013;248 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">14966374</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;mmerle T., Molla A., Wimmer E., Mutational analysis of the proposed FG loop of poliovirus proteinase 3C identifies amino acids that are necessary for 3CD cleavage and might be determinants of a function distinct from proteolytic activity. J. Virol. 66, 6028&#x2013;6034 (1992).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC241480</ArticleId><ArticleId IdType="pubmed">1326654</ArticleId></ArticleIdList></Reference><Reference><Citation>Andino R., Rieckhof G. E., Achacoso P. L., Baltimore D., Poliovirus RNA synthesis utilizes an RNP complex formed around the 5&#x2032;-end of viral RNA. EMBO J. 12, 3587&#x2013;3598 (1993).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC413634</ArticleId><ArticleId IdType="pubmed">8253083</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J. et al. ., Prevention of cell death by antibodies selected from intracellular combinatorial libraries. Chem. Biol. 21, 274&#x2013;283 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24440080</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan Y. M., Moustafa I. M., Arnold J. J., Cameron C. E., Boehr D. D., Long-range communication between different functional sites in the picornaviral 3C protein. Structure 24, 509&#x2013;517 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4824962</ArticleId><ArticleId IdType="pubmed">27050688</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker P. A., Leong L. E., Porter A. G., Sequence and structural determinants of the interaction between the 5&#x2032;-noncoding region of picornavirus RNA and rhinovirus protease 3C. J. Biol. Chem. 270, 14510&#x2013;14516 (1995).</Citation><ArticleIdList><ArticleId IdType="pubmed">7782313</ArticleId></ArticleIdList></Reference><Reference><Citation>Blair W. S. et al. ., Utilization of a mammalian cell-based RNA binding assay to characterize the RNA binding properties of picornavirus 3C proteinases. RNA 4, 215&#x2013;225 (1998).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1369610</ArticleId><ArticleId IdType="pubmed">9570321</ArticleId></ArticleIdList></Reference><Reference><Citation>Agbowuro A. A., Huston W. M., Gamble A. B., Tyndall J. D. A., Proteases and protease inhibitors in infectious diseases. Med. Res. Rev. 38, 1295&#x2013;1331 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29149530</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen A., Allosteric regulation of protease activity by small molecules. Mol. Biosyst. 6, 1431&#x2013;1443 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4356121</ArticleId><ArticleId IdType="pubmed">20539873</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesan R., Eigenbrot C., Kirchhofer D., Structural and mechanistic insight into how antibodies inhibit serine proteases. Biochem. J. 430, 179&#x2013;189 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20704569</ArticleId></ArticleIdList></Reference><Reference><Citation>Farady C. J., Egea P. F., Schneider E. L., Darragh M. R., Craik C. S., Structure of an Fab-protease complex reveals a highly specific non-canonical mechanism of inhibition. J. Mol. Biol. 380, 351&#x2013;360 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2478700</ArticleId><ArticleId IdType="pubmed">18514224</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider E. L. et al. ., A reverse binding motif that contributes to specific protease inhibition by antibodies. J. Mol. Biol. 415, 699&#x2013;715 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3268006</ArticleId><ArticleId IdType="pubmed">22154938</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y. et al. ., Structural insight into distinct mechanisms of protease inhibition by antibodies. Proc. Natl. Acad. Sci. U.S.A. 104, 19784&#x2013;19789 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2148376</ArticleId><ArticleId IdType="pubmed">18077410</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesan R. et al. ., Unraveling the allosteric mechanism of serine protease inhibition by an antibody. Structure 17, 1614&#x2013;1624 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">20004165</ArticleId></ArticleIdList></Reference><Reference><Citation>Kromann-Hansen T. et al. ., Allosteric inactivation of a trypsin-like serine protease by an antibody binding to the 37- and 70-loops. Biochemistry 52, 7114&#x2013;7126 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24079451</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinkofer L. C. et al. ., A monoclonal antibody (MCPR3-7) interfering with the activity of proteinase 3 by an allosteric mechanism. J. Biol. Chem. 288, 26635&#x2013;26648 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3772210</ArticleId><ArticleId IdType="pubmed">23902773</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez T. et al. ., Functional selection of protease inhibitory antibodies. Proc. Natl. Acad. Sci. U.S.A. 116, 16314&#x2013;16319 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6697876</ArticleId><ArticleId IdType="pubmed">31363054</ArticleId></ArticleIdList></Reference><Reference><Citation>Heikkinen T., J&#xe4;rvinen A., The common cold. Lancet 361, 51&#x2013;59 (2003).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7112468</ArticleId><ArticleId IdType="pubmed">12517470</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadam R. U. et al. ., Potent peptidic fusion inhibitors of influenza virus. Science 358, 496&#x2013;502 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5659926</ArticleId><ArticleId IdType="pubmed">28971971</ArticleId></ArticleIdList></Reference><Reference><Citation>Erlanson D. A. et al. ., Site-directed ligand discovery. Proc. Natl. Acad. Sci. U.S.A. 97, 9367&#x2013;9372 (2000).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC16870</ArticleId><ArticleId IdType="pubmed">10944209</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner S., Lerner R. A., Encoded combinatorial chemistry. Proc. Natl. Acad. Sci. U.S.A. 89, 5381&#x2013;5383 (1992).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC49295</ArticleId><ArticleId IdType="pubmed">1608946</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B., Stjepanovic G., Shen Q., Martin A., Hurley J. H., Vps4 disassembles an ESCRT-III filament by global unfolding and processive translocation. Nat. Struct. Mol. Biol. 22, 492&#x2013;498 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4456219</ArticleId><ArticleId IdType="pubmed">25938660</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>